Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Margin: 2009-2019

Historic Net Margin for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 4.70%.

  • Neurocrine Biosciences' Net Margin rose 2988.00% to 7.60% in Q3 2021 from the same period last year, while for Sep 2021 it was 3.67%, marking a year-over-year decrease of 529.00%. This contributed to the annual value of 4.70% for FY2019, which is 2.00% up from last year.
  • As of FY2019, Neurocrine Biosciences' Net Margin stood at 4.70%, which was up 0.37% from 4.68% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Net Margin registered a high of 4.70% during FY2019, and its lowest value of -950.28% during FY2017.
  • Over the past 3 years, Neurocrine Biosciences' median Net Margin value was 4.68% (recorded in 2018), while the average stood at -313.63%.
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by 47,457bps in 2016, then spiked by 95,496bps in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Net Margin stood at -466.03% in 2015, then tumbled by 47,457bps to -940.60% in 2016, then plummeted by 968bps to -950.28% in 2017, then skyrocketed by 95,496bps to 4.68% in 2018, then increased by 2bps to 4.70% in 2019.